For: | Pilotto A, Franceschi M, Leandro G, Scarcelli C, D’Ambrosio LP, Paris F, Annese V, Seripa D, Andriulli A, Di Mario F. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. World J Gastroenterol 2007; 13(33): 4467-4472 [PMID: 17724802 DOI: 10.3748/wjg.v13.i33.4467] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i33/4467.htm |
Number | Citing Articles |
1 |
Motoyasu Kusano, Shikou Kuribayashi, Osamu Kawamura, Yasuyuki Shimoyama, Hiroko Hosaka, Atsuto Nagoshi, Hiroaki Zai, Masatomo Mori. A Review of the Management of Gastric Acid-Related Diseases: Focus on Rabeprazole. Clinical Medicine. Gastroenterology 2011; 4: CGast.S5133 doi: 10.4137/CGast.S5133
|
2 |
M. A. Osadchuk, A. A. Svistunov, N. V. Kireeva, M. M. Osadchuk. Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problem. Terapevticheskii arkhiv 2020; 92(2): 111 doi: 10.26442/00403660.2020.02.000458
|
3 |
F.M. Huerta-Iga, J.L. Tamayo-de la Cuesta, A. Noble-Lugo, J.M. Remes-Troche, M.A. Valdovinos-Díaz, R.I. Carmona-Sánchez. Consenso mexicano de enfermedad por relujo gastroesofágico. Parte I. Revista de Gastroenterología de México 2012; 77(4): 193 doi: 10.1016/j.rgmx.2012.10.002
|
4 |
Cátia Santos-Pereira, María T. Andrés, José F. Fierro, Lígia R. Rodrigues, Manuela Côrte-Real. A review on lactoferrin as a proton pump inhibitor. International Journal of Biological Macromolecules 2022; 202: 309 doi: 10.1016/j.ijbiomac.2022.01.075
|
5 |
Claudine M. Baldwin, Susan J. Keam. Rabeprazole. Drugs 2009; 69(10): 1373 doi: 10.2165/00003495-200969100-00007
|
6 |
Boris D. Starostin. Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2019; 29(1): 7 doi: 10.22416/1382-4376-2019-29-1-7-16
|
7 |
A. Pilotto, S. Maggi, M. Noale, M. Franceschi, G. Parisi, G. Crepaldi. Development and Validation of a New Questionnaire for the Evaluation of Upper Gastrointestinal Symptoms in the Elderly Population: A Multicenter Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2010; (2): 174 doi: 10.1093/gerona/glp073
|
8 |
X. M. Xia, H. Wang. Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/327571
|
9 |
Marilisa Franceschi, Francesco Di Mario, Gioacchino Leandro, Stefania Maggi, Alberto Pilotto. Acid-related disorders in the elderly. Best Practice & Research Clinical Gastroenterology 2009; 23(6): 839 doi: 10.1016/j.bpg.2009.10.004
|
10 |
Shaojun Shi, Ulrich Klotz. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. European Journal of Clinical Pharmacology 2008; 64(10): 935 doi: 10.1007/s00228-008-0538-y
|
11 |
Vandana Boparai, Jaishree Rajagopalan, George Triadafilopoulos. Guide to the Use of Proton Pump Inhibitors in Adult Patients. Drugs 2008; 68(7): 925 doi: 10.2165/00003495-200868070-00004
|
12 |
Chao Zhang, Joey S. W. Kwong, Rui-Xia Yuan, Hao Chen, Chang Xu, Yi-Pin Wang, Gong-Li Yang, Jin-Zhu Yan, Le Peng, Xian-Tao Zeng, Hong Weng, Jie Luo, Yu-Ming Niu. Effectiveness and Tolerability of Different Recommended Doses of PPIs and H2RAs in GERD: Network Meta-Analysis and GRADE system. Scientific Reports 2017; 7(1) doi: 10.1038/srep41021
|
13 |
E. Márquez-Contreras, V. Gil, J. López, M. J. Plazas, J. Heras, J. Galván, J. Porcel. Pharmacological compliance and acceptability of lansoprazole orally disintegrating tablets in primary care. Current Medical Research and Opinion 2008; 24(2): 569 doi: 10.1185/030079908X261104
|
14 |
Kazuyoshi Hirota, Atsushi Imai, Mihoko Kudo, Hiroshi Hashimoto, Tetsuya Kushikata. Efficacy of a single 24‐hour pre‐anesthetic dose of proton pump inhibitors. Journal of Gastroenterology and Hepatology 2009; 24(7): 1244 doi: 10.1111/j.1440-1746.2009.05850.x
|
15 |
Naoki Chiba, M Brian Fennerty. Evidence‐Based Gastroenterology and Hepatology. 2010; : 17 doi: 10.1002/9781444314403.ch2
|
16 |
Viktoriia Prikhodko, Diana Moreva. Features of the Course and Treatment of Hypertension in Combination with Chronicis Chemic Heart Disease in Patients with Gastroesophagel Refluxdisease. Role of Proton Pump Inhibitors Test in the Diagnosis and Treatment of Different Forms of GERD. Family medicine 2016; (4): 75 doi: 10.30841/2307-5112.4.2016.248527
|
17 |
Stefano Pallotta, Fabio Pace, Silvia Marelli. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease. Expert Review of Gastroenterology & Hepatology 2008; 2(4): 509 doi: 10.1586/17474124.2.4.509
|
18 |
Muhammad Rizwan Umer, Wendy E. Mejia Crespo, Sana Dugan, Hamna Javed, Muhammad Suleman, Muhammad Waqas Afzal, Hassan Mumtaz, Muhammad Saqib, Haris Mumtaz Malik, Muhammad Iftikhar. Lansoprazole plus levosulpiride versus esomeprazole in participants with gastroesophageal reflux disease and erosive esophagitis: a double blinded randomized control trial. Annals of Medicine & Surgery 2023; 85(10): 4866 doi: 10.1097/MS9.0000000000001235
|